Results 231 to 240 of about 3,868,024 (353)

Evolving Research and Development Landscape for Rare Diseases: Growing Concerns Over Orphan Drug Lag in Japan. [PDF]

Clin Pharmacol Ther
Enya K, Kageyama I, Kobayashi Y, Lim Y, Sengoku S, Kodama K.   +5 more
europepmc   +1 more source

BL3 A CONCEPTUAL MODEL FOR POMPE DISEASE:THE BACKBONE FOR AN ECONOMIC EVALUATION OF AN ORPHAN DRUG

, 2010
TA Kanters, Ken Redekop, MLC Hagemans, der van, A. van der Ploeg, Leona Hakkaart‐van Roijen   +5 more
openalex   +1 more source

The challenge of accessing orphan drugs in the Middle East: A critical review [PDF]

, 2013
Ziyad S. Almalki, Abdullah K. Alahmari, Jeff J. Guo, C.M. Kelton   +3 more
openalex   +1 more source

Genetic variation among progeny shapes symbiosis in a basidiomycete with poplar

New Phytologist, EarlyView.
Summary Forest trees rely on ectomycorrhizal (ECM) fungi for acquiring scarce resources such as water and nutrients. However, the molecular mechanisms governing ECM traits remain inadequately understood, particularly the role of intraspecific fungal variation in root‐tip colonisation and trophic interactions.
Benjamin Dauphin, Maíra de Freitas Pereira, Daniel Croll, Thalita Cardoso Anastácio, Laure Fauchery, Frédéric Guinet, Maurício Dutra Costa, Francis Martin, Martina Peter, Annegret Kohler   +9 more
wiley   +1 more source

Weight Loss‐Associated Remodeling of Adipose Tissue Immunometabolism

Obesity Reviews, EarlyView.
ABSTRACT Obesity is a multifactorial condition characterized by excessive adiposity and systemic chronic low‐grade inflammation. Recent literature reflects a growing appreciation for the complex interplay between metabolism and the immune system in the pathogenesis of obesity‐related health conditions.
Paulo José Basso, Alejandro Schcolnik‐Cabrera, Mengyi Zhu, Erin Strachan, Xavier Clemente‐Casares, Sue Tsai   +5 more
wiley   +1 more source

PHP100 EVALUATION OF ACCEPTANCE AND REJECTION RATES OF ORPHAN DRUGS ACROSS SIX HTA AGENCIES

, 2010
Anne Jäkel, K Alnwick
openalex   +1 more source

Pharmacogenetic Interventions, Orphan Groups, and Distributive Justice: The Role of Cost-Benefit Analysis [PDF]

, 2002
Rai, Arti K.
core   +1 more source

Drug Price and Health Policy Knowledge Influence Prescription Behavior in Orphan Diseases: Pheochromocytoma and Paraganglioma As Prototypes of Orphan Drug Econometrics. [PDF]

Cureus
Le DQ, Burton BN, Tejeda CJ, Hong JC, Lee JS, Kamdar N.   +5 more
europepmc   +1 more source

Combined assessment of early and late-phase outcomes in orphan drug development. [PDF]

Stat Med, 2021
Pateras K, Nikolakopoulos S, Roes KCB.
europepmc   +1 more source

PHP9 BUDGET IMPACT ANALYSIS OF ORPHAN DRUGS IN BELGIUM: ESTIMATES FROM 2008 TO 2013

, 2010
A. Denis, Lut Mergaert, Christel Fostier, Irina Cleemput, Steven Simoens   +4 more
openalex   +1 more source